| |
| |
|
| Insider
Information: |
Parmar Kush |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
1,775 |
|
|
Indirect Shares
|
13,684,571 |
|
|
| Direct
Value |
$56,392 |
|
|
|
Indirect Value
|
$4,971,319 |
|
|
| Total
Shares |
13,686,346 |
|
|
| Total
Value |
$5,027,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -78.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Q32 Bio Inc |
QTTB |
Director |
2018-04-02 |
0 |
2020-12-22 |
181,435 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Director |
2019-09-24 |
1,775 |
2019-09-16 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
10% Owner |
2019-10-07 |
0 |
2020-06-16 |
313,497 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
Director, 10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
5:01 Acquisition Corp. |
FVAM |
Co-CEO, Director, 10% ... |
2020-10-16 |
0 |
2020-11-12 |
365,126 |
Premium* |
|
|
Vor Biopharma Inc. |
VOR |
Director, 10% Owner |
2021-02-09 |
0 |
2021-11-16 |
1,766,634 |
Premium* |
|
|
Rallybio Corp |
RLYB |
Director |
2021-07-28 |
0 |
2023-03-07 |
3,630,724 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
Premium* |
|
|
Cincor Pharma, Inc. |
CINC |
10% Owner |
2022-01-11 |
0 |
2022-01-11 |
496,323 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
|
0 |
2023-02-23 |
5,798,475 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLYB |
Rallybio Corp |
Director |
– • – |
2023-03-07 |
4 |
S |
$8.20 |
$820,000 |
I/I |
(100,000) |
2,378,969 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2023-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,798,475 |
|
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • • |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,135,786) |
0 |
0 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • • |
2022-06-03 |
4 |
S |
$12.50 |
$1,875,000 |
I/I |
(150,000) |
1,251,755 |
0 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • • |
2022-05-23 |
4 |
S |
$13.00 |
$1,300,000 |
I/I |
(100,000) |
1,302,084 |
0 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2022-02-08 |
4 |
S |
$13.05 |
$2,740,500 |
I/I |
(210,000) |
1,335,637 |
0 |
- |
|
| CINC |
Cincor Pharma, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
B |
$16.00 |
$7,520,000 |
I/I |
470,000 |
496,323 |
1.5 |
- |
|
| CINC |
Cincor Pharma, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,867,646 |
183,823 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Director |
– • • |
2021-11-16 |
4 |
S |
$15.30 |
$5,059,802 |
I/I |
(330,706) |
1,766,634 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • • |
2021-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,827,224 |
882,357 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • • |
2021-11-02 |
4 |
B |
$20.00 |
$5,000,000 |
I/I |
250,000 |
1,132,357 |
2.25 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • • |
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
331,155 |
|
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-08-02 |
4 |
B |
$13.00 |
$7,999,992 |
I/I |
615,384 |
1,406,098 |
2.1 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
3,575,340 |
790,714 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
Director |
– • • |
2021-02-09 |
4 |
B |
$18.00 |
$9,999,990 |
I/I |
555,555 |
1,858,470 |
2.25 |
- |
|
| VOR |
Vor Biopharma Inc. |
Director |
– • • |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,136,874 |
1,414,026 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • • |
2020-12-29 |
4 |
S |
$18.00 |
$8,460,000 |
I/I |
(470,000) |
982,453 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
Director |
– • – |
2020-12-22 |
4 |
S |
$12.82 |
$6,410,000 |
I/I |
(500,000) |
181,435 |
0 |
% |
|
| QTTB |
Q32 Bio Inc |
Director |
– • – |
2020-12-14 |
4 |
S |
$11.88 |
$6,125,915 |
I/I |
(500,000) |
201,435 |
0 |
% |
|
| FVAM |
5:01 Acquisition Corp. |
Co-CEO |
• • • |
2020-11-12 |
4 |
A |
$10.00 |
$51,260 |
I/I |
5,126 |
365,126 |
0 |
- |
|
| FVAM |
5:01 Acquisition Corp. |
Co-CEO |
• • • |
2020-10-16 |
4 |
A |
$10.00 |
$3,600,000 |
I/I |
360,000 |
360,000 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • • |
2020-06-30 |
4 |
B |
$17.00 |
$4,999,989 |
I/I |
294,117 |
1,094,101 |
2.25 |
- |
|
| AKUS |
Akouos, Inc. |
Director |
– • • |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,311,667 |
799,984 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
10% Owner |
– – • |
2020-06-16 |
4 |
S |
$33.30 |
$4,662,000 |
I/I |
(140,000) |
313,497 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
10% Owner |
– – • |
2020-06-11 |
4 |
S |
$28.75 |
$7,044,412 |
I/I |
(245,000) |
80,772 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
